Drug Information

Drug General Information
Drug ID
D04LTF
Former ID
DNC014898
Drug Name
TLN-4601
Drug Type
Small molecular drug
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 2 [522396]
Formula
C28H34N2O4
Canonical SMILES
CC(=CCCC(=CCCC(=CCN1C2=CC(=CC(=C2NC3=C(C1=O)C=CC=C3O)O)<br />O)C)C)C
InChI
1S/C28H34N2O4/c1-18(2)8-5-9-19(3)10-6-11-20(4)14-15-30-23-16-21(31)17-25(33)27(23)29-26-22(28(30)34)12-7-13-24(26)32/h7-8,10,12-14,16-17,29,31-33H,5-6,9,11,15H2,1-4H3/b19-10+,20-14+
InChIKey
SALVHVNECODMJP-GNUCVDFRSA-N
PubChem Compound ID
9868980
PubChem Substance ID
14833926, 24160205, 45291244, 71825016, 79272066, 87550990, 103691118, 139292001, 163642567, 172919730, 198979381, 242082175
Target and Pathway
Target(s) Peripheral-type benzodiazepine receptor Target Info Modulator
KEGG Pathway Neuroactive ligand-receptor interaction
HTLV-I infection
References
Ref 522396ClinicalTrials.gov (NCT00730262) Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme. U.S. National Institutes of Health.